These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 45047)

  • 1. [In vitro measurement of antacid capacity of commonly employed antacids (author's transl)].
    Csendes A; Antezana C; Meneses G
    Rev Med Chil; 1979 Nov; 107(11):1014-21. PubMed ID: 45047
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro determination of the neutralizing capacity of antacids].
    Brunner H
    Z Gastroenterol; 1983 Mar; 21 Suppl():22-5. PubMed ID: 6858407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Buffering capacity and cost of fluid antacids in 1977].
    Güller R
    Schweiz Med Wochenschr; 1977 Jun; 107(23):807-10. PubMed ID: 877531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro studies on antacids/Third communication (author's transl)].
    Schnekenburger J
    Arzneimittelforschung; 1981; 31(8):1286-90. PubMed ID: 6271146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro study of the antipeptic activity of antacid preparations].
    Pawlaczyk J; Kokot Z; Rafińska A
    Acta Pol Pharm; 1985; 42(2):153-8. PubMed ID: 3936340
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of the methods of in vitro evaluation of the neutralizing properties of drugs from the antacid group].
    Pawlaczyk J; Kokot Z; Urbowicz G; Ewertowska D
    Acta Pol Pharm; 1989; 46(3):272-9. PubMed ID: 2618772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical evaluation of a new concentrated antacid. I. Effects on gastric pH.
    Powell RL; Westlake WJ; Longaker ED; Greene LC
    J Clin Pharmacol New Drugs; 1971; 11(4):288-95. PubMed ID: 4932745
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro evaluation of liquid antacid products.
    Sherrill MC; Rudd GD
    Am J Hosp Pharm; 1982 Feb; 39(2):300-2. PubMed ID: 7058802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of duodenal ulcers with antacid mixtures and sulpiride. A double-blind controlled study (author's transl)].
    Lam SK; Lam KC; Lai CL; Yeung CK; Yam LY; Wong WS
    Sem Hop; 1978 Dec 8-15; 54(43-44):1404-7. PubMed ID: 219500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Method for determining the acid-reducing capacity of antacid preparations].
    Chakŭrski I; Dobrev Kh; Dobreva P
    Vutr Boles; 1986; 25(6):33-5. PubMed ID: 3564432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antacids: A comparison of their in vitro neutralizing capacity in hydrochloric acid and in acidified peptone solution (author's transl)].
    Walther C; Herzog P; Hissnauer KH; Kühl HJ; Holtermüller KH
    Z Gastroenterol; 1982 May; 20(5):263-72. PubMed ID: 7102017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of antacid on gastric and duodenal bulb acidity.
    Hannibal S; Remvig L; Rune SJ
    Scand J Gastroenterol Suppl; 1980; 58():29-36. PubMed ID: 6929092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro study of the neutralizing effect of the most frequently used antacids].
    Matincheva R; Antonov P; Kiratsov E
    Vutr Boles; 1983; 22(5):43-7. PubMed ID: 6689508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of different therapeutic schedules of antacids on the pH of gastric content, varying dosage and time of administration, in patients with duodenal ulcer].
    Ribeiro TC; Coelho LG; Avelar CD; Castro LP
    AMB Rev Assoc Med Bras; 1984; 30(7-8):144-6. PubMed ID: 6395220
    [No Abstract]   [Full Text] [Related]  

  • 15. [Duodenal ulcer treated by carbenoxolone sodium. Endoscopically controlled trial (author's transl)].
    Carrilho FJ; Onishi I; Soares EC; Zeitune JM; Pareja JC; Amorim Filho J
    Arq Gastroenterol; 1978; 15(4):167-74. PubMed ID: 749854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ulcers. 8. Antacid treatment].
    Dotevall G; Walan A
    Lakartidningen; 1966 Dec; 63(50):4843-7. PubMed ID: 5977897
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cimetidin treatment of duodenal ulcer resistant to antacid therapy (author's transl)].
    Massarrat S; Heuser E; Schubotz R
    Leber Magen Darm; 1979 Feb; 9(1):20-4. PubMed ID: 763061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods for the assessment of antacids. In-vitro and in-vivo investigations with gastric aspiration.
    Keyriläinen O
    Scand J Gastroenterol Suppl; 1982; 75():40-3. PubMed ID: 6959249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative in vitro research on 2 new antacid combinations--Ulsan and Ulsan D].
    Chakŭrski I; Dobrev Kh; Dobreva P
    Vutr Boles; 1987; 26(5):86-90. PubMed ID: 3433734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro comparison of the antacid potencies of almagate in tablets and suspension with those of other commercially available antacid preparations.
    Prieto R; Martinez-Tobed A; Fábregas JL; Beneyto JE
    Arzneimittelforschung; 1984; 34(10A):1360-4. PubMed ID: 6548920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.